AMGEN at AHA

Addressing Gaps in Cardiovascular Health

Cardiovascular disease is one of the most significant public health issues in the world. Our commitment to cardiovascular disease remains steadfast, and supporting cross-sector collaborative programs and patient-advocacy initiatives is part of this commitment. A key focus of this work is moving from a reactive healthcare model toward a proactive and innovative public health approach aimed to predict and prevent the impact of serious diseases from occurring. Together, we are employing and testing not just one approach but a range of innovative initiatives to help improve patient outcomes and address population health.

Check. Change. Control. Cholesterol™

Amgen has partnered with American Heart Association on Check. Change. Control. Cholesterol™ program, which aims to reduce the number of Americans who have heart attacks and strokes by improving cholesterol management of high-risk cardiovascular disease patients through a multifaceted approach.

See the Program

TRANSFORM: ACS

Amgen has partnered with American College of Cardiology (ACC) on TRANSFORM: ACS, a program that aims to initiate lipid-lowering treatment closer to hospital discharge for ACS patients.

View Press Release

Alliance for the Million Hearts®

Amgen is part of the CDC Foundation’s Alliance for the Million Hearts campaign, an initiative focused on changing the way people think about and embrace CVD prevention — promoting simple and sustained steps that people can take to help protect their heart health.

Read the Article